You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -96.8% | -137.6% |
| ROCE | 1,632.2% |
| Latest | Forecast | |
|---|---|---|
| P/E | -7.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 10.8 | 10.2 |
| Price / Book value | 11.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 140.8% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 5.51 | -18.05 | -12.98p | -1.3 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 2.14 | -18.86 | -7.27p | -15.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 2.94 | -29.19 | -10.57p | -12.0 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 9.65 | -41.64 | -14.48p | -7.9 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | 23.25 | -27.32 | -9.15p | -12.7 | 0.0 | n/a | n/a | 0.0% |
| Avacta Group appoints new non-executive chair Sharecast News | 20 Jun |
|---|---|
| Avacta reports further progress in chemotherapy trial Sharecast News | 23 May |
| Avacta reaches milestone in AVA6000 dose escalation Sharecast News | 21 Mar |
| Avacta Reported Updated Phase 1 Data of AVA6000 | 16-Sep-24 07:53 |
|---|---|
| Notice of Results | 12-Sep-24 13:16 |
| Avacta to present clinical data at ESMO Congress | 09-Sep-24 08:49 |
| Director/PDMR Shareholdings and TVR | 02-Sep-24 15:53 |
| Convertible Bond Payment | 18-Jul-24 07:01 |